CASTLE BIOSCIENCES, INC., Issuer AND [TRUSTEE], TrusteeCastle Biosciences Inc • December 14th, 2020 • Services-medical laboratories • New York
Indenture, dated as of [•], 20__, among Castle Biosciences, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):
CASTLE BIOSCIENCES, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20Debt Securities Warrant Agreement • December 14th, 2020 • Castle Biosciences Inc • Services-medical laboratories • New York
This DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between CASTLE BIOSCIENCES, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
CASTLE BIOSCENCES, INC. and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [ ], 20Common Stock Warrant Agreement • December 14th, 2020 • Castle Biosciences Inc • Services-medical laboratories • New York
This COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between CASTLE BIOSCIENCES, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
CASTLE BIOSCIENCES, INC. and , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [ ], 20Preferred Stock Warrant Agreement • December 14th, 2020 • Castle Biosciences Inc • Services-medical laboratories • New York
This PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between CASTLE BIOSCIENCES, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
